News

Helmsley Charitable Trust backs Vivli with funding to deliver data-sharing platform

Tuesday, November 14, 2017

Vivli has secured funding from The Leona M. and Harry B. Helmsley Charitable Trust to deliver an innovative data-sharing platform, which will make it easier to find, host and analyze clinical trial data across disease areas to accelerate medical research. This funding will augment what Vivli has already received and ensure that the platform is available for public use in 2018.

[Read More]

Marken launches app for clinical patients

Tuesday, November 14, 2017

Marken introduced the launch of a new online tool, Marken Viseo, which will allow patients to track their home deliveries of clinical trial materials and the pickup of their biological specimens via their mobile device or personal computer.

[Read More]

Diversity in clinical trials critical to refining medicines and therapies

Tuesday, November 14, 2017

Leaders from Northwell Health’s Feinstein Institute for Medical Research, the FDA and Boehringer Ingelheim recently led a symposium on the barriers and opportunities to increase patient diversity in clinical trials. Because medicines may affect people differently based on age, sex and race, the diversity of clinical trial participants is important to better anticipate differences in treatment effects once the medicines are on the market.

[Read More]

Myriad collaborates with Department of Veterans Affairs

Tuesday, November 14, 2017

Assurex Health, a wholly-owned subsidiary of Myriad Genetics, announced that the Department of Veterans Affairs (VA) recently initiated a national, multicenter trial to evaluate the company’s GeneSight test to help improve health outcomes for veterans diagnosed with major depressive disorder (MDD). Approximately 20% of the 2.6 million veterans who deployed to Iraq or Afghanistan returned with MDD or a related mental health condition, and tragically suicide rates for veterans are twice that of the U.S. population.

[Read More]